Nasser, Azmi http://orcid.org/0000-0003-0514-8410
Gomeni, Roberto
Ceresoli-Borroni, Gianpiera
Xie, Lanyi
Busse, Gregory D.
Melyan, Zare
Rubin, Jonathan
Article History
Received: 12 August 2022
Accepted: 10 March 2024
First Online: 5 April 2024
Declarations
:
: Ethics approval was not required, as the study was conducted using computer simulations.
: GC, LX, GDB, ZM, and JR are employees of Supernus Pharmaceuticals, Inc.AN was an employee of Supernus Pharmaceuticals, Inc. at the time the study was conducted.RG was a paid consultant to Ironshore Pharmaceuticals, Sunovion Pharmaceuticals, Supernus Pharmaceuticals, Teva, Biomedical Science Institutes, Nanomi BVs, Laboratorios Liconsa, Massachusetts General Hospital, UCB, Recordati Rare Diseases, Indivior, Tris Pharma, and F. Hoffmann-La Roche.